Feb 20, 2026Evidence 9.0/10Elevated
WOLVERINE STACK
What it does: Coverage is focused on recovery, skin and tissue repair, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Recovery 10.0Skin & repair 7.1
Feb 20, 2026Evidence 9.0/10Moderate
VIP PEPTIDE
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 7.1Weight loss 6.0
Feb 20, 2026Evidence 9.5/10Moderate
VILON
What it does: Coverage is focused on healthy aging, performance, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Longevity 8.3Performance 6.2
Feb 20, 2026Evidence 9.8/10Very Low
TRIPTORELIN
What it does: Coverage is focused on performance, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Performance 7.2Weight loss 5.2
Feb 20, 2026Evidence 9.5/10Low
TIRZEPATIDE
What it does: Coverage is focused on weight management, cognition, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Weight loss 10.0Cognition 8.3
Feb 20, 2026Evidence 9.3/10Moderate
THYMOSIN ALPHA-1
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 5.1Longevity 5.1
Feb 20, 2026Evidence 9.5/10Moderate
THYMALIN
What it does: Coverage is focused on healthy aging, cognition, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational rat...
Longevity 8.3Cognition 7.2
Feb 20, 2026Evidence 9.8/10Very Low
TESAMORELIN
What it does: Coverage is focused on weight management, performance, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Weight loss 8.7Performance 6.3
Feb 20, 2026Evidence 9.8/10Very Low
TEDUGLUTIDE
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 7.3Longevity 5.2
Feb 20, 2026Evidence 9.0/10Moderate
TB-500
What it does: Coverage is focused on recovery, performance, and skin and tissue repair, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Recovery 10.0Performance 6.0
Feb 20, 2026Evidence 7.6/10Moderate
SS-31
What it does: Coverage is focused on weight management, recovery, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 6.6Recovery 6.6
Feb 20, 2026Evidence 6.5/10Moderate
Sermorelin
What it does: Coverage is focused on performance, recovery, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...
Performance 7.1Recovery 6.2
Feb 20, 2026Evidence 9.4/10Moderate
Semax
What it does: Coverage is focused on cognition, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational rat...
Cognition 10.0Longevity 6.1
Feb 20, 2026Evidence 9.0/10Very Low
SEMAGLUTIDE
What it does: Coverage is focused on weight management, cognition, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Weight loss 10.0Cognition 8.1
Feb 20, 2026Evidence 6.5/10Moderate
Selank
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 9.5Weight loss 4.1
Feb 20, 2026Evidence 9.5/10Moderate
RETINALAMIN
What it does: Coverage is focused on recovery, healthy aging, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational rat...
Recovery 7.2Longevity 6.2
Feb 20, 2026Evidence 9.4/10Low
Retatrutide
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 10.0Longevity 5.1
Feb 20, 2026Evidence 9.0/10Moderate
PT-141
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 6.0Weight loss 5.0
Feb 20, 2026Evidence 9.5/10Moderate
PROSTATILEN
What it does: Coverage is focused on recovery, performance, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...
Recovery 6.2Performance 6.2
Feb 20, 2026Evidence 9.5/10Low
PRAMLINTIDE
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 7.2Longevity 5.1
Feb 20, 2026Evidence 9.8/10Low
PLECANATIDE
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 5.2Longevity 5.2
Feb 20, 2026Evidence 9.0/10Moderate
PINEALON
What it does: Coverage is focused on cognition, healthy aging, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 10.0Longevity 8.1
Feb 20, 2026Evidence 9.8/10Very Low
PASIREOTIDE
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 5.2Longevity 5.2
Feb 20, 2026Evidence 9.8/10Low
OCTREOTIDE
What it does: Coverage is focused on performance, cognition, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informatio...
Performance 6.3Cognition 6.3
Feb 20, 2026Evidence 8.8/10Moderate
MOTS-C
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 8.4Longevity 5.9
Feb 20, 2026Evidence 7.0/10Moderate
MODIFIED GRF 1-29
What it does: Coverage is focused on weight management, cognition, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informatio...
Weight loss 6.4Cognition 6.4
Feb 20, 2026Evidence 7.3/10Elevated
Melanotan 2
What it does: Coverage is focused on weight management, skin and tissue repair, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treate...
Weight loss 5.4Skin & repair 5.4
Feb 20, 2026Evidence 9.0/10Moderate
Melanotan 1
What it does: Coverage is focused on skin and tissue repair, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treate...
Skin & repair 6.0Weight loss 5.0
Feb 20, 2026Evidence 8.5/10Moderate
LL-37
What it does: Coverage is focused on recovery, skin and tissue repair, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as ...
Recovery 9.0Skin & repair 6.9
Feb 20, 2026Evidence 9.0/10Low
LIRAGLUTIDE
What it does: Coverage is focused on weight management, performance, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Weight loss 10.0Performance 6.0
Feb 20, 2026Evidence 9.8/10Low
LINACLOTIDE
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 5.2Longevity 5.2
Feb 20, 2026Evidence 9.8/10Very Low
LEUPROLIDE ACETATE
What it does: Coverage is focused on performance, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Performance 6.1Weight loss 5.2
Feb 20, 2026Evidence 9.8/10Low
LANREOTIDE
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 6.3Weight loss 5.2
Feb 20, 2026Evidence 8.8/10Moderate
KPV (LYS-PRO-VAL)
What it does: Coverage is focused on recovery, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Recovery 7.1Weight loss 4.9
Feb 20, 2026Evidence 8.5/10Moderate
Kisspeptin
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 5.8Weight loss 4.8
Feb 20, 2026Evidence 6.9/10Moderate
Ipamorelin
What it does: Coverage is focused on weight management, recovery, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...
Weight loss 6.3Recovery 6.3
Feb 20, 2026Evidence 7.0/10Elevated
IBUTAMOREN (MK-677)
What it does: Coverage is focused on weight management, performance, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...
Weight loss 7.4Performance 7.3
Feb 20, 2026Evidence 7.6/10Elevated
HUMANIN
What it does: Coverage is focused on healthy aging, weight management, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Longevity 8.7Weight loss 6.6
Feb 20, 2026Evidence 9.5/10Moderate
HUMAN RELAXIN-2
What it does: Coverage is focused on recovery, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Recovery 6.2Weight loss 5.1
Feb 20, 2026Evidence 9.4/10Very Low
HMG
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 5.1Longevity 5.1
Feb 20, 2026Evidence 8.1/10Moderate
HGH FRAGMENT 176-191
What it does: Coverage is focused on weight management, performance, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Weight loss 6.7Performance 5.7
Feb 20, 2026Evidence 7.1/10Moderate
Hexarelin
What it does: Coverage is focused on performance, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Performance 8.3Weight loss 5.3
Feb 20, 2026Evidence 9.5/10Very Low
HCG
What it does: Coverage is focused on weight management, cognition, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Weight loss 8.3Cognition 6.2
Feb 20, 2026Evidence 9.5/10Very Low
GONADORELIN
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 6.2Weight loss 5.1
Feb 20, 2026Evidence 9.5/10Moderate
GLP-1
What it does: Coverage is focused on weight management, performance, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informatio...
Weight loss 10.0Performance 6.2
Feb 20, 2026Evidence 7.1/10Elevated
GHRP-6
What it does: Coverage is focused on performance, weight management, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...
Performance 7.3Weight loss 6.4
Feb 20, 2026Evidence 6.5/10Elevated
GHRP-2
What it does: Coverage is focused on performance, weight management, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...
Performance 7.1Weight loss 6.2
Feb 20, 2026Evidence 7.0/10Moderate
GHRELIN
What it does: Coverage is focused on weight management, cognition, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational...
Weight loss 8.5Cognition 6.4
Feb 20, 2026Evidence 9.0/10Moderate
GHK-Cu
What it does: Coverage is focused on skin and tissue repair, recovery, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as info...
Skin & repair 10.0Recovery 9.2
Feb 20, 2026Evidence 9.5/10Moderate
GDF-11
What it does: Coverage is focused on healthy aging, performance, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational ...
Longevity 6.2Performance 6.2
Feb 20, 2026Evidence 9.2/10High
FOXO4-DRI
What it does: Coverage is focused on recovery, skin and tissue repair, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as info...
Recovery 9.2Skin & repair 7.1
Feb 20, 2026Evidence 9.5/10Elevated
FOLLISTATIN 344
What it does: Coverage is focused on recovery, weight management, and performance, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as information...
Recovery 7.2Weight loss 6.2
Feb 20, 2026Evidence 9.5/10Very Low
EXENATIDE
What it does: Coverage is focused on weight management, healthy aging, and cognition, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Weight loss 10.0Longevity 7.2
Feb 20, 2026Evidence 6.2/10Moderate
Epitalon
What it does: Coverage is focused on healthy aging, cognition, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Longevity 7.1Cognition 5.0
Feb 20, 2026Evidence 9.5/10Very Low
DULAGLUTIDE
What it does: Coverage is focused on weight management, healthy aging, and recovery, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informati...
Weight loss 10.0Longevity 5.1
Feb 20, 2026Evidence 7.3/10Moderate
DSIP (Delta Sleep-Inducing Peptide)
What it does: Coverage is focused on cognition, recovery, and weight management, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informational...
Cognition 6.5Recovery 5.4
Feb 20, 2026Evidence 8.7/10Elevated
Dihexa
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 10.0Weight loss 4.8
Feb 20, 2026Evidence 9.5/10Moderate
DEMOXYTOCIN
What it does: Coverage is focused on cognition, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as informat...
Cognition 7.2Weight loss 5.1
Feb 20, 2026Evidence 9.8/10Very Low
DEGARELIX
What it does: Coverage is focused on performance, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treated as inform...
Performance 6.1Weight loss 5.2
Feb 20, 2026Evidence 9.4/10Moderate
DECAPEPTIDE-12
What it does: Coverage is focused on skin and tissue repair, weight management, and healthy aging, with interpretation framed around published studies and known mechanism hypotheses. Findings are context-dependent and should be treate...
Skin & repair 7.2Weight loss 5.1
Radar cards are editorial summaries for education. They are not clinical guidance. Always verify against primary studies and product labeling.